Neomorph
James Rader currently serves as a Senior Scientist at Neomorph, Inc., a position held since July 2021. Prior to this role, James Rader contributed to Bristol Myers Squibb as a Senior Scientist from November 2019 to July 2021. Earlier in the career, James Rader worked at Celgene, starting as a Scientist I and advancing to Senior Associate Scientist from February 2017 to November 2019.
Neomorph
1 followers
Neomorph is a venture backed biotechnology company solving critical problems in human health through the discovery and development of innovative new medicines against ‘undruggable targets’.